Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatofibrosarcoma protuberans.

William M Mendenhall1, Robert A Zlotecki, Mark T Scarborough

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA. mendewil@shands.ufl.edu

Cancer
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rosai-Dorfman Disease: The Role of Radiation Therapy.

Practical radiation oncology·2025
Same author

Orthopaedic Oncologic Consultation Using Asynchronous Telemedicine: Expedited Triage and Reduced Clinic Visits.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2025
Same author

Telemedicine in Orthopedic Oncology: An Opportunity for Cost Savings Without Compromising Clinical Outcomes.

Orthopedics·2024
Same author

CORR Insights®: What Is the Revision-free Survival of Resurfaced Allograft-prosthesis Composites for Proximal Humerus Reconstruction in Children With Bone Tumors?

Clinical orthopaedics and related research·2024
Same author

Answering the Call for Radiation Oncologists to Direct Radiopharmaceutical Therapy: Forget the Professional Fee and Get the Hospital to Pay for Support Staff, Infrastructure, and Supplies.

Practical radiation oncology·2023
Same author

CORR Insights®: Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?

Clinical orthopaedics and related research·2023
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
Same journal

Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

Cancer·2026
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
See all related articles

Dermatofibrosarcoma protuberans (DFSP) is a rare skin tumor. Optimal treatment involves wide margin resection, with radiotherapy aiding local control in high-risk cases.

Area of Science:

  • Dermatology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing cutaneous tumor.
  • A subset of DFSP cases (10-15%) exhibit fibrosarcoma components (DFSP-FS), correlating with increased aggressiveness.

Purpose of the Study:

  • To review the natural history of DFSP.
  • To discuss current treatment modalities for DFSP and DFSP-FS.

Main Methods:

  • Literature review focusing on DFSP epidemiology, clinical behavior, and treatment outcomes.
  • Analysis of surgical and radiotherapy approaches for DFSP management.

Main Results:

  • Wide margin resection offers >90% local control for DFSP.

Related Experiment Videos

  • Postoperative radiotherapy improves local control to >/= 85% in patients with close or positive margins.
  • Metastasis rates for DFSP are low (

    • Conclusions:

    • Surgical resection with wide margins is the primary treatment for DFSP.
    • Adjuvant radiotherapy is crucial for managing positive/close margins and unresectable disease.
    • Radiotherapy as a standalone treatment for macroscopic DFSP has limited supporting data.